Comparison of 3 Modes of Genetic Counseling in High-Risk Public Hospital Patients (GC3Modes)
Comparison of 3 Modes of Genetic Counseling in High-Risk Public Hospital
Sponsor: National Cancer Institute (NCI)
A NA clinical study on Genetic Counseling, this trial is completed. The trial is conducted by National Cancer Institute (NCI) and has accumulated 12 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Apr 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Apr 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Sep 2021 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jan 2021 — Sep 2021 [monthly]
Active Not Recruiting NA
▶ Show 7 earlier versions
-
Sep 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Feb 2020 — Sep 2020 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Sep 2019 — Feb 2020 [monthly]
Recruiting NA
-
Feb 2019 — Sep 2019 [monthly]
Recruiting NA
-
Jun 2018 — Feb 2019 [monthly]
Recruiting NA
-
Nov 2017 — Jun 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jan 2017 — Nov 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- National Cancer Institute (NCI)
- National Institutes of Health (NIH)
- University of California, Davis
- University of California, San Francisco
For direct contact, visit the study record on ClinicalTrials.gov .